5//SEC Filing
GRANADILLO PEDRO P 5
Accession 0001140361-21-005130
CIK 0001281895other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 9:57 PM ET
Size
16.1 KB
Accession
0001140361-21-005130
Insider Transaction Report
Form 5
GRANADILLO PEDRO P
Director
Transactions
- Gift
Stock Option (Right to Buy)
2020-12-28−30,000→ 0 totalExercise: $14.56Exp: 2029-01-28→ Common Stock (30,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-28+40,000→ 40,000 total(indirect: By Trust)Exercise: $18.75Exp: 2028-03-29→ Common Stock (40,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-28+30,000→ 30,000 total(indirect: By Trust)Exercise: $14.56Exp: 2029-01-28→ Common Stock (30,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-28−40,000→ 0 totalExercise: $18.75Exp: 2028-03-29→ Common Stock (40,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-28−20,000→ 0 totalExercise: $19.90Exp: 2030-06-16→ Common Stock (20,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-28+20,000→ 20,000 total(indirect: By Trust)Exercise: $19.90Exp: 2030-06-16→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, all of which are currently vested and exercisable.
- [F2]This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 37,778 of which are currently vested and exercisable, with the remaining 2,222 shares vesting in equal monthly installments on each of February 28, 2021 and March 29, 2021.
- [F3]This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001217544
Filing Metadata
- Form type
- 5
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 9:57 PM ET
- Size
- 16.1 KB